These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4039611)

  • 1. Enhanced plasminogen-activator production by leukocytes in the human and murine Chediak-Higashi syndrome.
    de Saint Basile G; Fischer A; Dautzenberg MD; Durandy A; Le Deist F; Angles-Cano E; Griscelli C
    Blood; 1985 May; 65(5):1275-81. PubMed ID: 4039611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal bactericidal, metabolic, and lysosomal functions of Chediak-Higashi Syndrome leukocytes.
    Root RK; Rosenthal AS; Balestra DJ
    J Clin Invest; 1972 Mar; 51(3):649-65. PubMed ID: 4400956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific protease deficiency in polymorphonuclear leukocytes of Chédiak-Higashi syndrome and beige mice.
    Vassalli JD; Granelli-Piperno A; Griscelli C; Reich E
    J Exp Med; 1978 Apr; 147(4):1285-90. PubMed ID: 650154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of protease inhibitors by postsurgical macrophages.
    Fukasawa M; Campeau JD; Girgis W; Bryant SM; Rodgers KE; DiZerega GS
    J Surg Res; 1989 Mar; 46(3):256-61. PubMed ID: 2493532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies of adenine nucleotide biochemistry in the Chediak-Higashi syndrome.
    Jamison KC; Padgett GA; Giesy JP; Bell TG
    Exp Mol Pathol; 1993 Feb; 58(1):40-52. PubMed ID: 8384120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Chediak-Higashi syndrome: microtubules in monocytes and lymphocytes.
    White JG; Clawson CC
    Am J Hematol; 1979; 7(4):349-56. PubMed ID: 546223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Chédiak-Higashi syndrome: ring-shaped lysomomes in circulating monocytes.
    White JG; Clawson CC
    Am J Pathol; 1979 Sep; 96(3):781-98. PubMed ID: 474718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical studies on the leukocytes in Chediak-Higashi syndrome.
    Zabucchi G; Cramer R; Soranzo MR; Tamaro P; Panizon F
    Acta Haematol; 1977; 58(1):50-7. PubMed ID: 199018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced diacylglycerol production by phospholipase D activation is responsible for abnormal increase in concanavalin A cap formation in polymorphonuclear leukocytes from Chediak-Higashi syndrome (beige) mice.
    Kasai H; Tanabe F
    Int Immunopharmacol; 2014 Jul; 21(1):193-9. PubMed ID: 24830864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correction of characteristic abnormalities of microtubule function and granule morphology in Chediak-Higashi syndrome with cholinergic agonists.
    Oliver JM; Zurier RB
    J Clin Invest; 1976 May; 57(5):1239-47. PubMed ID: 1262469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasminogen activator production by bovine milk macrophages and blood monocytes.
    Politis I; Zhao X; McBride BW; Burton JH; Turner JD
    Am J Vet Res; 1991 Aug; 52(8):1208-13. PubMed ID: 1928901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective lysosomal exocytosis and plasma membrane repair in Chediak-Higashi/beige cells.
    Huynh C; Roth D; Ward DM; Kaplan J; Andrews NW
    Proc Natl Acad Sci U S A; 2004 Nov; 101(48):16795-800. PubMed ID: 15557559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorescent cytometric analysis of polymorphonuclear leukocytes in Chediak-Higashi syndrome: diminished C3bi receptor expression (OKM1) with normal granular cell density.
    Cairo MS; Vandeven C; Toy C; Tischler D; Sender L
    Pediatr Res; 1988 Dec; 24(6):673-6. PubMed ID: 2974532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tubulin tyrosinolation in human polymorphonuclear leukocytes: studies in normal subjects and in patients with the Chediak-Higashi syndrome.
    Nath J; Flavin M; Gallin JI
    J Cell Biol; 1982 Nov; 95(2 Pt 1):519-26. PubMed ID: 6754747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chediak-Higashi syndrome presenting in accelerated phase: A case report and literature review.
    Maaloul I; Talmoudi J; Chabchoub I; Ayadi L; Kamoun TH; Boudawara T; Kallel CH; Hachicha M
    Hematol Oncol Stem Cell Ther; 2016 Jun; 9(2):71-5. PubMed ID: 26254864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the lysosomal storage disease Chediak-Higashi syndrome.
    Ward DM; Griffiths GM; Stinchcombe JC; Kaplan J
    Traffic; 2000 Nov; 1(11):816-22. PubMed ID: 11208072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-related accumulation of ceroid-like pigment in mice with Chediak-Higashi syndrome.
    Oliver C; Essner E; Zimring A; Haimes H
    Am J Pathol; 1976 Aug; 84(2):225-38. PubMed ID: 941977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant transformation of human fibroblasts correlates with increased activity of receptor-bound plasminogen activator.
    Jankun J; Maher VM; McCormick JJ
    Cancer Res; 1991 Feb; 51(4):1221-6. PubMed ID: 1847659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chediak-Higashi syndrome presenting in accelerated phase.
    Imran T; Zafar L; Rehan M; Nasir A; Tariq PA; Batool I
    J Coll Physicians Surg Pak; 2012 Aug; 22(8):539-41. PubMed ID: 22868026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defective granulocyte chemotaxis in the Chediak-Higashi syndrome.
    Clark RA; Kimball HR
    J Clin Invest; 1971 Dec; 50(12):2645-52. PubMed ID: 4942966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.